share_log

Canaccord Genuity Maintains Buy on Tenaya Therapeutics, Lowers Price Target to $18

Moomoo 24/7 ·  Mar 20 07:44

Canaccord Genuity analyst Whitney Ijem maintains Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and lowers the price target from $19 to $18.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment